Vimarsana
Biggest News Aggregation in the World

C Reactive News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from C Reactive. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In C Reactive Today - Breaking & Trending Today

LumiraDx launches Rapid Microfluidic Immunoassay C-Reactive Protein Test to help combat Antimicrobial Resistance in India - Vimarsana News

LumiraDx launches Rapid Microfluidic Immunoassay C-Reactive Protein Test to help combat Antimicrobial Resistance in India

Published: November 24, 2022

Mumbai (Maharashtra) [India], November 24 (ANI/NewsVoir): LumiraDx Healthcare Private Limited, a next-generation point of care diagnostics testing company, announced it has launched its highly sensitive C-Reactive Protein (CRP) point of care antigen test across India.

Source: webindia123.com
Related Topics:
City OfUnited KingdomYogesh SinghVander SticheleNigel LindnerNeelam TanejaMegha SharmaLumiradx Healthcare PrivateWorld Health OrganisationLumiradx Healthcare Private LimitedC Reactive ProteinWorld Antimicrobial Awareness WeekCare Antigen TestLumiradx General ManagerChief Innovation OfficerReactive Protein TestingGuide Antibiotic PrescribingHealth OrganisationWellcome TrustC ReactiveEws India
Low-Dose Rituximab May Keep RA Activity Low in Responders - Vimarsana News

Low-Dose Rituximab May Keep RA Activity Low in Responders

Published: November 20, 2021

Rituximab doses as low as 200 mg were effective in treating rheumatoid arthritis, an extension study of a small trial in the Netherlands found.

Source: medscape.com
Related Topics:
Maya BuchCentre For Musculoskeletal ResearchRadboud Institute For Health Sciences In NijmegenUniversity Of Manchester EnglandAmerican College Of RheumatologyMaarten ClinicRadboud InstituteHealth SciencesAmerican CollegeDisease Activity ScoreExperimental MedicineMusculoskeletal ResearchRheumatoid ArthritisAntineoplastic DrugNti Cancer AgentsBiologic TherapyMonoclonal AntibodyClinical ResearchClinical TrialsLinical StudiesDisease Modifying Antirheumatic Drugs Dmards Mard Disease Modifying Antirheumatic Drug Adverse EffectsSide EffectsC Reactive